Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells. Duangjai, A; Luo, K; Zhou, Y; Yang, J; and KOPECEK, J Eur J Pharm Biopharm, 87(1):187--196, May, 2014.
bibtex   
@article{ Duangjai:2014fxa,
  author = {Duangjai, A and Luo, K and Zhou, Y and Yang, J and KOPECEK, J},
  title = {{Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells}},
  journal = {Eur J Pharm Biopharm},
  year = {2014},
  volume = {87},
  number = {1},
  pages = {187--196},
  month = {May},
  annote = {Duangjai, Acharaporn
Luo, Kui
Zhou, Yan
Yang, Jiyuan
Kopecek, Jindrich
eng
P30 CA042014/CA/NCI NIH HHS/
R01 CA051578/CA/NCI NIH HHS/
R01 CA51578/CA/NCI NIH HHS/
R41 CA156933/CA/NCI NIH HHS/
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Netherlands
2013/12/10 06:00
Eur J Pharm Biopharm. 2014 May;87(1):187-96. doi: 10.1016/j.ejpb.2013.11.008. Epub 2013 Dec 4.}
}
Downloads: 0